The status of receptors in the management of endometrial cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011374:Progesterone / Q000627:therapeutic use; D011379:Prognosis; D011980:Receptors, Progesterone / Q000032:analysis*; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D000970:Antineoplastic Agents; D011980:Receptors, Progesterone; D011374:Progesterone; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone